What is the price-to-earnings ratio of Yuhan?
The price-earnings ratio of Yuhan is currently 39.24.
Yuhan P/E 2024
Yuhan P/E
39.24
Ticker
000100.KS
ISIN
KR7000100008
As of Nov 16, 2024, Yuhan's P/E ratio was 39.24, a 16.37% change from the 33.72 P/E ratio recorded in the previous year.
The Yuhan P/E history
Yuhan Aktienanalyse
What does Yuhan do?
The Yuhan Corporation is a South Korean conglomerate that was founded on September 1, 1926, under the name "Chosun Pharmaceutical Company". The company is headquartered in Seoul and employs more than 5,000 people worldwide. History: The Yuhan Corporation started as a small company with a single product, a fish oil-based ointment called "Yuksundo". The company worked hard to improve its products and expand its market, eventually expanding into other business areas such as the production of antibiotics and diabetes treatments. In the early 1950s, the company also ventured into the research and development of other pharmaceuticals. In 1962, Yuhan became a publicly traded company and received a variety of awards in the following years, including several Korean Industrial Awards. Since its inception, the company has remained committed to improving people's lives through innovation and science. Business model: The Yuhan Corporation is a pharmaceutical company that focuses on the development, manufacturing, and marketing of drugs and other health products. The company also makes investments in innovative technologies and healthcare startups. Over the years, Yuhan has expanded its business through partnerships with other companies and acquisitions of companies such as LGL Holdings and SillaJen Inc. The company also engages in international business relations, such as selling its products and medications in other countries. Divisions: The Yuhan Corporation has four main business divisions: Medical Research and Development, Drug Manufacturing, Biotechnology Product Development, and Health Product Production. The first division is coordinated by Yuhan Research & Development Co. Ltd, while drug manufacturing is done by Yuhan Manufacturing Co. Ltd. Biotechnology is done by Yuhan Biomedical Research Institute, and the health product segment is handled by Yuhan Healthcare. Products: Yuhan's products are diverse and include a wide range of drugs and health products. The company is involved in the production of antibiotics, analgesics, vein treatment agents, diabetes medications, cardiovascular drugs, and other pharmaceutical products. Other products also include cosmetics, oral care products, and dermatology drugs. Some of Yuhan's well-known products include the antibiotic Ceclor, a medication for the treatment of diabetes and metabolic disorders, as well as apple-based cosmetic products. All Yuhan products are manufactured according to strict quality standards and are known for their effectiveness and safety. Conclusion: The Yuhan Corporation has evolved into a diverse and innovative company focused on the production of drugs and health products. The company has a long history with many successes and has established itself as one of the major forces in the South Korean economy over the past decades. Yuhan's mission to create better healthcare remains as relevant today as it was at the time of its founding. Yuhan ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering Yuhan's P/E Ratio
The Price to Earnings (P/E) Ratio of Yuhan is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing Yuhan's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of Yuhan is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in Yuhan’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about Yuhan stock
How has the price-earnings ratio of Yuhan changed compared to last year?
The price-to-earnings ratio of Yuhan has increased by 16.37% increased compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Yuhan high compared to other companies?
Yes, the price-to-earnings ratio of Yuhan is high compared to other companies.
How does an increase in the price-earnings ratio of Yuhan affect the company?
An increase in the price-earnings ratio of Yuhan would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Yuhan affect the company?
A decrease in the price-earnings ratio of Yuhan would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Yuhan?
Some factors that influence the price-earnings ratio of Yuhan are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Yuhan pay?
Over the past 12 months, Yuhan paid a dividend of 428.57 KRW . This corresponds to a dividend yield of about 0.36 %. For the coming 12 months, Yuhan is expected to pay a dividend of 443.36 KRW.
What is the dividend yield of Yuhan?
The current dividend yield of Yuhan is 0.36 %.
When does Yuhan pay dividends?
Yuhan pays a quarterly dividend. This is distributed in the months of January, January, January, January.
How secure is the dividend of Yuhan?
Yuhan paid dividends every year for the past 23 years.
What is the dividend of Yuhan?
For the upcoming 12 months, dividends amounting to 443.36 KRW are expected. This corresponds to a dividend yield of 0.37 %.
In which sector is Yuhan located?
Yuhan is assigned to the 'Health' sector.
Wann musste ich die Aktien von Yuhan kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Yuhan from 5/1/2024 amounting to 428.571 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2023.
When did Yuhan pay the last dividend?
The last dividend was paid out on 5/1/2024.
What was the dividend of Yuhan in the year 2023?
In the year 2023, Yuhan distributed 380.952 KRW as dividends.
In which currency does Yuhan pay out the dividend?
The dividends of Yuhan are distributed in KRW.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Yuhan
Our stock analysis for Yuhan Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Yuhan Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
